Riskpilot← Back to searchSign inGet full accessMERÅKER DYREKLINIKK AS
ASActiveOrg 923406484Mellomriksveien 4847, 7530 MeråkerVeterinary activities · NACE 7500Est. 20194 employees
Revenue 2024
NOK 2,1M
+7% vs 2023
EBITDA margin
19.7%
+110% vs 2023
Equity ratio
-0.5%
Financial strength
Net profit 2024
NOK 147K
+179% vs 2023
| Revenue | NOK 2,1M | +7% |
| EBITDA | NOK 411K | +110% |
| Net profit | NOK 147K | +179% |
| Total assets | NOK 1M | +35% |
| Equity | NOK -6K | +96% |
| Employees | 4 | — |
Legal name
MERÅKER DYREKLINIKK AS
Org number
923406484
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
17. september 2019
Share capital
NOK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Kjøp, salg og formidling av dyrehelsetjenester, dyrefôr og utstyr til dyr. Medvirke i andre selskap innen samme virksomhet.
Address
Mellomriksveien 4847, 7530 Meråker
Phone
+4772606051
Email
meraaker@blaapote.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 176 | 1 684 | 1 769 | 1 956 | 2 090 |
| Staff expenses | −484 | −718 | −737 | −603 | −526 |
| EBITDA | −86 | 84 | 119 | 196 | 411 |
| Depreciation & amort. | −91 | −104 | −104 | −104 | −113 |
| EBIT | −178 | −21 | 15 | 91 | 298 |
| Net financials | −48 | −42 | −27 | −39 | −151 |
| Profit before tax | −225 | −63 | −11 | 53 | 147 |
| Tax | 1 | −0 | −0 | −0 | −0 |
| Net profit | −227 | −63 | −11 | 53 | 147 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 945 | 826 | 783 | 768 | 1 038 |
| Equity | −131 | −194 | −205 | −152 | −6 |
| Long-term debt | 585 | 540 | 479 | 518 | 636 |
| Short-term debt | 492 | 479 | 509 | 402 | 408 |
| Total debt | 1 076 | 1 020 | 988 | 920 | 1 043 |
EBITDA margin
19.7%
This company
15.8%
Market median
+25% vs market
20202024
Equity ratio
-0.5%
This company
38.2%
Market median
-101% vs market
20202024
Return on equity
14687500.0%
This company
18.4%
Market median
+79823270% vs market
20202024
Net profit margin
7.0%
This company
8.1%
Market median
-14% vs market
20202024
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20202024
Debt / equity
187.95×
This company
0.62×
Market median
-30215% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 70% | 70% | 2024 | |
| Individual | 30% | 30% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Blå Pote As
MERÅKER DYREKLINIKK AS Board members of MERÅKER DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solveig Johanne Strøm Aaknes | Chief Executive Officer | 0 companies |
| Nicholas Alexander Morgan | Chairman | 0 companies |
| Sunniva Morgan | Board of Directors | 0 companies |